During the past decade, San Antonio Regional Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "San Antonio Regional Hospital" are "Atherosclerosis" (1 trials) and "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials). Many other conditions were trialed in "San Antonio Regional Hospital" in a lesser frequency.

Most popular intervention types in "San Antonio Regional Hospital" are "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eagle Eye Platinum digital IVUS catheter with optional SyncVision" (1 trials), "ExPEC9V" (1 trials), "Placebo" (1 trials) and "Resolute Onyx Drug Eluting Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Antonio Regional Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "San Antonio Regional Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in San Antonio Regional Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in San Antonio Regional Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".